论文部分内容阅读
为探索有效的抗流行性出血热(EHF)病毒的治疗方法。作者首次应用取自(EHF)患者恢复期血清制备的高效价免疫球蛋白(HTIG),对1987年10月~1988年5月41例早期EHF患者进行随机分组的实验研研。20例患者给予HTIG(补体结合效价>1:1280)1ml肌注,余21例给予生理盐水1ml肌注,作为对照。其他综合治疗两组相同,不用其他抗病毒药和免疫制剂。
To explore effective anti-epidemic hemorrhagic fever (EHF) virus treatment. The authors first applied high titer immunoglobulin (HTIG) from sera recovered from convalescent patients (EHF) to study the randomized study of 41 early EHF patients from October 1987 to May 1988. 20 patients were given HTIG (complement fixation titer> 1: 1280) 1ml intramuscular injection, the remaining 21 cases given saline 1ml intramuscular injection, as a control. Other comprehensive treatment of the same two groups, without other antivirals and immune agents.